These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 235609)

  • 21. Conformational energy differences between side chain alkylated analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
    Weintraub HJ; Nichols DE; Makriyannis A; Fesik SW
    J Med Chem; 1980 Mar; 23(3):339-41. PubMed ID: 7365752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
    Jacob P; Shulgin AT
    J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
    Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
    J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
    Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
    Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.
    Standridge RT; Howell HG; Tilson HA; Chamberlain JH; Holava HM; Gylys JA; Partyka RA; Shulgin AT
    J Med Chem; 1980 Feb; 23(2):154-62. PubMed ID: 7359529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromo-DMA: new hallucinogenic drug.
    Delliou D
    Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100
    [No Abstract]   [Full Text] [Related]  

  • 28. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between activity and electronic state of hallucinogenic amphetamines.
    Kang S; Green JP
    Nature; 1970 May; 226(5246):645. PubMed ID: 5444928
    [No Abstract]   [Full Text] [Related]  

  • 30. A reevaluation of psychotomimetic amphetamine derivatives in humans.
    Cassels BK; Gómez-Jeria JS
    J Psychoactive Drugs; 1985; 17(2):129-30. PubMed ID: 4020537
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 32. Stereospecific requirements for hallucinogenesis.
    Shulgin AT
    J Pharm Pharmacol; 1973 Mar; 25(3):271-2. PubMed ID: 4146335
    [No Abstract]   [Full Text] [Related]  

  • 33. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
    Glennon RA; Young R; Jacyno JM
    Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-METHOXY-4,5-METHYLENEDIOXY AMPHETAMINE, A NEW PSYCHOTOMIMETIC AGENT.
    SHULGIN AT
    Nature; 1964 Mar; 201():1120-1. PubMed ID: 14152788
    [No Abstract]   [Full Text] [Related]  

  • 35. Conformational analysis of sterols: comparison of X-ray crystallographic observations with data from other sources.
    Duax WL; Griffin JF; Rohrer DC; Weeks CM
    Lipids; 1980 Sep; 15(9):783-92. PubMed ID: 7421432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug dependence. A review of the narcotic and hallucinogenic effects of drugs].
    Haan J
    Med Monatsschr Pharm; 1981 May; 4(5):129-37. PubMed ID: 7024769
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.
    Rasmussen K; Aghajanian GK
    Brain Res; 1986 Oct; 385(2):395-400. PubMed ID: 3096493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
    Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
    Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on hallucinogens. IV. Synthesis of 2,5-dimethoxy-4-methylamphetamine (STP) (author's transl)].
    Ono M; Shimamine M; Takahashi K
    Eisei Shikenjo Hokoku; 1973; 91(0):41-44. PubMed ID: 4800136
    [No Abstract]   [Full Text] [Related]  

  • 40. [USE OF PSYCHOTROPIC DRUGS IN PSYCHOTHERAPY].
    STEVENIN L; BENOIT JC
    Acta Psychother Psychosom; 1964; 12():168-87. PubMed ID: 14162290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.